Decentralized Trials STREAM

  1. Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations 2/22/2023

    Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.

  2. Transformative Cardiac Solutions 7/30/2025

    While traditional ECGs require on-site visits, delaying data and increasing drop-out risk, AliveCor''s FDA-Cleared ECG devices can be used on-site as well as in decentralized and fully remote trials.

  3. What It Really Takes To Adopt eConsent Across Large Pharma 3/27/2024

    Explore the benefits of incorporating consent management technology and discover practical strategies for developing effective change management and training programs.

  4. Creating The Digital Foundation For Scale In Clinical Development 8/11/2023

    Learn how CROs, pharma, and biotechs are using digital trial methods to scale efficiencies across the entirety of their clinical trial portfolio for maximum ROI.

  5. A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data 2/25/2025

    Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

  6. Technology Overload: Addressing Site Challenges Of Digital Trials 5/23/2024

    Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.

  7. Trials And Tribulations Of Electronic Patient Consent: Removing Barriers To eConsent Adoption 6/3/2021

    After a decade of dabbling with eConsent, how can sponsors and technology providers meet the demand to bring clinical trials directly to the patient at a global scale? In this webinar, you’ll learn strategies to overcome the persistent challenges in eConsent adoption and gain the benefits promised from successful decentralized trials with remote capabilities for patients and sites.

  8. On-site ePRO Solutions For Flexible Data Collection Across Devices 3/17/2026

    Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.

  9. Enhancing Data Collection, Delivery, And Operational Efficiency 5/21/2025

    Remote and hybrid trial setup for cardiac monitoring can be challenging, with several but there are steps you can take to optimize cardiac monitoring workflows and data capture.

  10. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.